PURPOSE: To identify and characterize potentially avoidable hospitalizations in patients with GI malignancies. PATIENTS AND METHODS: We compiled a retrospective series of sequential hospital admissions in patients with GI cancer. Patients were admitted to an inpatient medical oncology or palliative care service between December 2011 and July 2012. Practicing oncology clinicians used a consensus-driven medical record review process to categorize each hospitalization as "potentially avoidable" or "not avoidable." Patient demographic and clinical data were abstracted, and quantitative and qualitative analyses were performed to identify patient characteristics and outcomes associated with potentially avoidable hospitalizations. RESULTS: We evaluated 201 hospitalizations in 154 unique patients. The median age was 62 years, and colorectal cancer was the most common diagnosis (32%). The majority of hospitalized patients had metastatic cancer (81%). In all, 53% of hospitalizations were attributable to cancer symptoms, and 28% were attributable to complications of cancer treatment. Medical oncologists identified 39 hospitalizations (19%) as potentially avoidable. Hospitalizations were more likely to be categorized as potentially avoidable for patients with the following characteristics: age ≥ 70 years (odds ratio [OR], 2.63; 95% CI, 1.15 to 6.02), receipt of an oncologist's advice to consider hospice (OR, 6.09; 95% CI, 2.54 to 14.58), or receipt of three or more lines of chemotherapy (OR, 2.68; 95% CI, 1.01 to 7.08). Ninety-day mortality was higher after avoidable hospitalizations compared with hospitalizations that were not avoidable (OR, 6.4; 95% CI, 1.8 to 22.3). CONCLUSION: Potentially avoidable hospitalizations are common in patients with advanced GI cancer. The majority of potentially avoidable hospitalizations occurred in patients with advanced treatment-refractory cancers near the end of life.
PURPOSE: To identify and characterize potentially avoidable hospitalizations in patients with GI malignancies. PATIENTS AND METHODS: We compiled a retrospective series of sequential hospital admissions in patients with GI cancer. Patients were admitted to an inpatient medical oncology or palliative care service between December 2011 and July 2012. Practicing oncology clinicians used a consensus-driven medical record review process to categorize each hospitalization as "potentially avoidable" or "not avoidable." Patient demographic and clinical data were abstracted, and quantitative and qualitative analyses were performed to identify patient characteristics and outcomes associated with potentially avoidable hospitalizations. RESULTS: We evaluated 201 hospitalizations in 154 unique patients. The median age was 62 years, and colorectal cancer was the most common diagnosis (32%). The majority of hospitalized patients had metastatic cancer (81%). In all, 53% of hospitalizations were attributable to cancer symptoms, and 28% were attributable to complications of cancer treatment. Medical oncologists identified 39 hospitalizations (19%) as potentially avoidable. Hospitalizations were more likely to be categorized as potentially avoidable for patients with the following characteristics: age ≥ 70 years (odds ratio [OR], 2.63; 95% CI, 1.15 to 6.02), receipt of an oncologist's advice to consider hospice (OR, 6.09; 95% CI, 2.54 to 14.58), or receipt of three or more lines of chemotherapy (OR, 2.68; 95% CI, 1.01 to 7.08). Ninety-day mortality was higher after avoidable hospitalizations compared with hospitalizations that were not avoidable (OR, 6.4; 95% CI, 1.8 to 22.3). CONCLUSION: Potentially avoidable hospitalizations are common in patients with advanced GI cancer. The majority of potentially avoidable hospitalizations occurred in patients with advanced treatment-refractory cancers near the end of life.
Authors: Gabriel A Brooks; Ling Li; Dhruv B Sharma; Jane C Weeks; Michael J Hassett; K Robin Yabroff; Deborah Schrag Journal: J Natl Cancer Inst Date: 2013-03-12 Impact factor: 13.506
Authors: Michael J Hassett; A James O'Malley; Juliana R Pakes; Joseph P Newhouse; Craig C Earle Journal: J Natl Cancer Inst Date: 2006-08-16 Impact factor: 13.506
Authors: R S Pritchard; E S Fisher; J M Teno; S M Sharp; D J Reding; W A Knaus; J E Wennberg; J Lynn Journal: J Am Geriatr Soc Date: 1998-10 Impact factor: 5.562
Authors: Lisa D DiMartino; Bryan J Weiner; Laura C Hanson; Morris Weinberger; Sarah A Birken; Katherine Reeder-Hayes; Justin G Trogdon Journal: J Palliat Med Date: 2017-08-03 Impact factor: 2.947
Authors: R D Nipp; A El-Jawahri; M Ruddy; C Fuh; B Temel; S M D'Arpino; B J Cashavelly; V A Jackson; D P Ryan; E P Hochberg; J A Greer; J S Temel Journal: Ann Oncol Date: 2019-02-01 Impact factor: 32.976
Authors: Gabriel A Brooks; Ankit J Kansagra; Sowmya R Rao; James I Weitzman; Erica A Linden; Joseph O Jacobson Journal: JAMA Oncol Date: 2015-07 Impact factor: 31.777
Authors: P Connor Johnson; Yian Xiao; Risa L Wong; Sara D'Arpino; Samantha M C Moran; Daniel E Lage; Brandon Temel; Margaret Ruddy; Lara N Traeger; Joseph A Greer; Ephraim P Hochberg; Jennifer S Temel; Areej El-Jawahri; Ryan D Nipp Journal: J Oncol Pract Date: 2019-04-04 Impact factor: 3.840
Authors: Claire Duflos; Sami Antoun; Philippe Loirat; Mario DiPalma; Etienne Minvielle Journal: Support Care Cancer Date: 2017-03-08 Impact factor: 3.603
Authors: Ryan D Nipp; Areej El-Jawahri; Sara M D'Arpino; Andy Chan; Charn-Xin Fuh; P Connor Johnson; Daniel E Lage; Risa L Wong; William F Pirl; Lara Traeger; Barbara J Cashavelly; Vicki A Jackson; David P Ryan; Ephraim P Hochberg; Jennifer S Temel; Joseph A Greer Journal: Cancer Date: 2018-06-15 Impact factor: 6.860
Authors: John Y Shin; Sani H Kizilbash; Steven I Robinson; Joon H Uhm; Julie E Hammack; Daniel H Lachance; Jan C Buckner; Aminah Jatoi Journal: J Neurooncol Date: 2016-03-15 Impact factor: 4.130